Trial record 1 of 1 for:    AN1792
Previous Study | Return to List | Next Study

Randomized Safety, Tolerability and Pilot Efficacy of AN-1792 in Alzheimer's Disease

This study has been terminated.
Sponsor:
Collaborator:
Wyeth is now a wholly owned subsidiary of Pfizer
Information provided by:
JANSSEN Alzheimer Immunotherapy Research & Development, LLC
ClinicalTrials.gov Identifier:
NCT00021723
First received: August 2, 2001
Last updated: September 22, 2009
Last verified: November 2001
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: September 2003
  Estimated Primary Completion Date: No date given